Liver Cancer
Targeted interventional radiology treatments for liver cancer including chemoembolization and radioembolization.
What It Is
IYA Medical offers advanced interventional radiology treatments for liver cancer including transarterial chemoembolization (TACE), radioembolization (Y-90), and tumor ablation. TACE delivers chemotherapy drugs directly to the tumor through the hepatic artery while simultaneously blocking the tumor's blood supply. Radioembolization uses tiny radioactive beads to deliver targeted radiation. Ablation uses heat or cold to destroy tumor cells.
Who It's For
These treatments are appropriate for patients with hepatocellular carcinoma (HCC), liver metastases from other cancers, patients who are not candidates for surgical resection, or those who need tumor reduction before transplant (bridge therapy). Patients with multiple tumors or compromised liver function may particularly benefit from these targeted approaches.
What to Expect
Procedures are performed under conscious sedation. A catheter is inserted through a small puncture in the groin and guided to the hepatic artery using real-time X-ray imaging. For TACE, chemotherapy beads are delivered directly to the tumor. For Y-90, radioactive microspheres are injected. Ablation procedures use a needle probe guided by CT or ultrasound. Procedures typically take 1-3 hours.
Recovery
Most patients stay overnight for observation. Post-embolization syndrome (mild fever, nausea, pain) is common for a few days and is managed with medication. Most patients return to normal activities within 1-2 weeks. Follow-up imaging at 4-6 weeks evaluates treatment response. Multiple sessions may be scheduled depending on tumor response.
Schedule a Consultation
Find out if this treatment is right for you. Our team will review your case and develop a personalized treatment plan.
Schedule Nowor call 480-771-0000